Mean Corpuscular Hemoglobin Concentration (MCHC) is a laboratory value reported as part of a complete blood count (CBC), a common blood test used in hematology and routine health analysis. MCHC estimates the average concentration of hemoglobin inside your red blood cells. Hemoglobin is the iron-containing protein that gives blood its red color and carries oxygen from your lungs to the rest of your body.

MCHC is calculated from other CBC measurements (mainly hemoglobin and hematocrit) and is typically reported in grams per deciliter (g/dL). In plain language, it helps describe whether red blood cells look appropriately “colored” with hemoglobin.

What results can mean:

Low MCHC usually means red blood cells have a lower-than-normal hemoglobin concentration, often described as hypochromic (paler cells). This commonly points toward problems with hemoglobin production, such as iron deficiency or certain inherited blood disorders.

Normal MCHC suggests that the average hemoglobin concentration inside red blood cells is within the expected range. Even with a normal MCHC, anemia can still be present, so your clinician will interpret it alongside other CBC indices (like MCV, MCH, RDW) and your symptoms.

High MCHC is less common and can be seen when red blood cells are more densely packed with hemoglobin or are unusually shaped or fragile. Sometimes this reflects specific blood disorders; other times it may be related to sample issues (for example, cell clumping) and may need confirmation.

MCHC is usually ordered automatically as part of a CBC, either during a routine checkup or when a clinician is evaluating symptoms that could be linked to anemia or other blood disorders. Because it reflects hemoglobin concentration within red blood cells, it helps narrow down the possible causes of anemia and guides further diagnostic testing.

Your clinician may order or closely review MCHC when you have symptoms such as:

Fatigue, weakness, low energy, shortness of breath with activity, dizziness or lightheadedness, headaches, pale skin, cold hands/feet, chest discomfort or palpitations, or reduced exercise tolerance.

It may also be checked when there are risk factors for anemia or abnormal red blood cell production, including:

Heavy menstrual bleeding, pregnancy, recent blood loss (surgery, injury, gastrointestinal bleeding), poor dietary iron intake, vegan/vegetarian diets without adequate iron planning, digestive conditions that reduce nutrient absorption (such as celiac disease), chronic inflammation or infection, kidney disease, family history of inherited hematology conditions (like thalassemia or hereditary spherocytosis), or use of certain medications that can affect blood counts.

Clinicians use MCHC along with other CBC values to distinguish patterns such as iron deficiency anemia (often low MCHC and microcytosis) versus other causes of anemia, and to determine whether additional tests—like ferritin/iron studies, vitamin B12/folate levels, reticulocyte count, or a peripheral blood smear—are needed.

• Iron deficiency anemia (often associated with low MCHC and hypochromic red blood cells)
• Thalassemia (inherited hemoglobin disorder; may show low MCHC)
• Anemia of chronic disease/inflammation (MCHC may be normal or low depending on severity and iron availability)
• Sideroblastic anemia (abnormal hemoglobin synthesis; may affect MCHC)
• Lead poisoning (can interfere with hemoglobin production and contribute to hypochromic anemia)
• Hereditary spherocytosis (can be associated with higher MCHC due to red cell shape changes)
• Autoimmune hemolytic anemia (may show higher MCHC in some cases, and abnormal red cell indices overall)
• Chronic blood loss (e.g., gastrointestinal bleeding, heavy menstrual bleeding) leading to iron deficiency and low MCHC

• Screening for anemia and supporting general wellness during routine checkups (as part of a CBC blood test)
• Evaluating fatigue and low energy to determine whether low hemoglobin or iron deficiency may be contributing
• Monitoring iron status and response to iron supplementation or dietary changes (alongside ferritin and iron studies)
• Pregnancy and postpartum health monitoring for anemia risk and recovery after blood loss
• Tracking chronic conditions (e.g., inflammatory disease or kidney disease) that can impact blood counts and oxygen delivery
• Assessing nutritional health, including possible deficiencies that affect red blood cells (iron, and sometimes related nutrient issues)
• Following known blood disorders over time as part of ongoing hematology care and health analysis